QNCX
Price
$1.55
Change
+$0.05 (+3.33%)
Updated
Jun 27 closing price
Capitalization
80.56M
44 days until earnings call
SRZN
Price
$9.02
Change
+$0.67 (+8.02%)
Updated
Jun 27 closing price
Capitalization
77.05M
Interact to see
Advertisement

QNCX vs SRZN

Header iconQNCX vs SRZN Comparison
Open Charts QNCX vs SRZNBanner chart's image
Quince Therapeutics
Price$1.55
Change+$0.05 (+3.33%)
Volume$140.26K
Capitalization80.56M
Surrozen
Price$9.02
Change+$0.67 (+8.02%)
Volume$23.83K
Capitalization77.05M
QNCX vs SRZN Comparison Chart in %
Loading...
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
QNCX vs. SRZN commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QNCX is a Buy and SRZN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (QNCX: $1.55 vs. SRZN: $9.02)
Brand notoriety: QNCX and SRZN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QNCX: 34% vs. SRZN: 155%
Market capitalization -- QNCX: $80.82M vs. SRZN: $77.23M
QNCX [@Biotechnology] is valued at $80.82M. SRZN’s [@Biotechnology] market capitalization is $77.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QNCX’s FA Score shows that 0 FA rating(s) are green whileSRZN’s FA Score has 0 green FA rating(s).

  • QNCX’s FA Score: 0 green, 5 red.
  • SRZN’s FA Score: 0 green, 5 red.
According to our system of comparison, QNCX is a better buy in the long-term than SRZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QNCX’s TA Score shows that 5 TA indicator(s) are bullish while SRZN’s TA Score has 5 bullish TA indicator(s).

  • QNCX’s TA Score: 5 bullish, 4 bearish.
  • SRZN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both QNCX and SRZN are a good buy in the short-term.

Price Growth

QNCX (@Biotechnology) experienced а +19.23% price change this week, while SRZN (@Biotechnology) price change was -9.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

QNCX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QNCX($80.6M) and SRZN($77M) have the same market capitalization . QNCX YTD gains are higher at: -17.112 vs. SRZN (-37.143). SRZN has higher annual earnings (EBITDA): -24.62M vs. QNCX (-40.25M). SRZN has more cash in the bank: 102M vs. QNCX (31.6M). SRZN has less debt than QNCX: SRZN (7.97M) vs QNCX (15.8M). SRZN has higher revenues than QNCX: SRZN (11.6M) vs QNCX (0).
QNCXSRZNQNCX / SRZN
Capitalization80.6M77M105%
EBITDA-40.25M-24.62M164%
Gain YTD-17.112-37.14346%
P/E RatioN/AN/A-
Revenue011.6M-
Total Cash31.6M102M31%
Total Debt15.8M7.97M198%
FUNDAMENTALS RATINGS
QNCX: Fundamental Ratings
QNCX
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
QNCXSRZN
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 19 days ago
84%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
QNCX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FMCKI11.040.04
+0.36%
Freddie Mac
AIPG0.01N/A
N/A
AI TECHNOLOGY GROUP INC.
BNPJY1.60N/A
N/A
Banpu Public Co., Ltd.
MFGI25.05N/A
N/A
Merchants Financial Group, Inc.
TRATF31.40N/A
N/A
Traton SE

QNCX and

Correlation & Price change

A.I.dvisor tells us that QNCX and MNPR have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QNCX and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
+3.33%
MNPR - QNCX
31%
Poorly correlated
-4.03%
KOD - QNCX
28%
Poorly correlated
-2.38%
MDXG - QNCX
27%
Poorly correlated
N/A
LQDA - QNCX
24%
Poorly correlated
+2.10%
SRZN - QNCX
24%
Poorly correlated
+8.02%
More

SRZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRZN has been loosely correlated with RNTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SRZN jumps, then RNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRZN
1D Price
Change %
SRZN100%
+8.02%
RNTX - SRZN
44%
Loosely correlated
-4.55%
INAB - SRZN
39%
Loosely correlated
-1.39%
IRON - SRZN
34%
Loosely correlated
+0.68%
KMSTF - SRZN
34%
Loosely correlated
N/A
INBX - SRZN
32%
Poorly correlated
-2.43%
More